EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Average Dose of Anti-Snake Venom in Snake Bite Patients Admitted in National Poison Control Center (NPCC) Karachi, Pakistan

Gouhar Rehman Peerzada, Muhammad Inam Khan, Syed Riaz ul Hassan, Muhammad Omer Sultan, Ashar Shahid, Desaar Zehra

Journal of Medical & Health Sciences Review · 20.07.2025 · 2 (2) · 374-378

DOI: 10.65035/vg1xsp40 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical & Health Sciences Review, online erschienen am 20.07.2025. Verfasst von Gouhar Rehman Peerzada und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

History of Snake bite is as Old as mankind and a Major Public Health Issues in Pakistan, particularly in rural in peri-urban populations. Anti-snake venom (ASV) remains the cornerstone of treatment, but optimal dosing various depending on clinical severity and time management of the treatment of the hospitalized patients.

Objective

To analyze the average dose of anti-snake venom (ASV) administered to snake bite patients at National Poison Control Center (NPCC) Jinnah Postgraduate Medical Center (JPMC) Karachi Pakistan and correlate the dosage severity and time of treatment and management of hospitalized patients. Methodology: A Prospective Observational Study conducted on 110 Patients presenting with snake bite at National Poison Control Center (NPCC) Jinnah Post Graduate Medical Center (JPMC) between January 2025 to May 2025 Data are classified on the bases of age, gender, severity (Mild, Moderate, Severe, Very Severe) and time interval between bite and treatment were analyzed.

Result

The result shoes Mild envenomation cases required 50-100 ml ASV Moderate cases typically received 150-300 ml ASV and Severe cases required 300 ml to 1000 ml ASV or more then depending on the condition and treatment protocol and management. A strong correlation was Observe between Severity on the envenomation and ASV dose which are significantly increase the requirements of ASV Protocol.

Conclusion

ASV dosing regimen at NPCC follow a severity-based approach rather than a fixed-dose regimen and early hospital presentation reduces ASV requirements and improves patient’s outcomes.

Zitieren

APA

Peerzada, G. R., Khan, M. I., Hassan, S. R. U., Sultan, M. O., Shahid, A., & Zehra, D. (2025). Average Dose of Anti-Snake Venom in Snake Bite Patients Admitted in National Poison Control Center (NPCC) Karachi, Pakistan. Journal of Medical & Health Sciences Review, 2(2), 374-378. https://doi.org/10.65035/vg1xsp40

Vancouver

Peerzada GR, Khan MI, Hassan SRU, Sultan MO, Shahid A, Zehra D. Average Dose of Anti-Snake Venom in Snake Bite Patients Admitted in National Poison Control Center (NPCC) Karachi, Pakistan. Journal of Medical & Health Sciences Review. 2025;2(2):374-378. doi:10.65035/vg1xsp40

BibTeX
@article{Peerzada2025,
  author = {Peerzada, Gouhar Rehman and Khan, Muhammad Inam and Hassan, Syed Riaz ul and Sultan, Muhammad Omer and Shahid, Ashar and Zehra, Desaar},
  title = {Average Dose of Anti-Snake Venom in Snake Bite Patients Admitted in National Poison Control Center (NPCC) Karachi, Pakistan},
  journal = {Journal of Medical & Health Sciences Review},
  year = {2025},
  volume = {2},
  number = {2},
  pages = {374--378},
  doi = {10.65035/vg1xsp40}
}
Kostenlos starten →